Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries

HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2005-09, Vol.40 (1), p.12-19
Hauptverfasser: Chai, Hong, Yang, Hui, Yan, Shaoyu, Li, Min, Lin, Peter H, Lumsden, Alan B, Yao, Qizhi, Chen, Changyi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 12
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume 40
creator Chai, Hong
Yang, Hui
Yan, Shaoyu
Li, Min
Lin, Peter H
Lumsden, Alan B
Yao, Qizhi
Chen, Changyi
description HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.
doi_str_mv 10.1097/01.qai.0000172368.05327.7b
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21047565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>901464671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</originalsourceid><addsrcrecordid>eNpdkduO0zAQhiMEYg_wCshaCe5SfHbCXVXtodJKIAF7aznJWPWS2l07UeHtmdJKlfCNPeNvZn77r6obRheMtuYzZYsXFxYUFzNc6GZBleBmYbpX1SVrpaxN08jXeFZc1ZIJdVFdlfKMuJayfVtdMM2wzqjLan_rPfRTIckTRR7WT-RbThO4AmQdN6ELU8p4GcmTK2mbMCJ3c-yngCkXB_J93kFOv8MAZBkPSSwf5uN9wCjlPkQgq5RTdPkPWeYJcoDyrnrj3Vjg_Wm_rn7e3f5YPdSPX-_Xq-Vj3SvKeS0a0O1AufLOQe_bofMSnAbFqGQIMOV9Z1SrvFCNASGM8o3WjaRsYI3uxHX16dh3l9PLDGWy21B6GEcXIc3FcmxklFYI3vwHPqc5R9RmuRCaN1oIhL4coT6nUjJ4u8thi--yjNqDN5Yyi97Yszf2nzfWHKR8OE2Yuy0M59KTGQh8PAGu9G702cU-lDNnmDBUaeTkkdunEX-z_BrnPWS7ATdOGxzNOGqVNadU0ZYyWh_UcPEXbL6ntg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233628633</pqid></control><display><type>article</type><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><source>Freely Accessible Journals</source><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><creator>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</creator><creatorcontrib>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</creatorcontrib><description>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/01.qai.0000172368.05327.7b</identifier><identifier>PMID: 16123675</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Animals ; Antioxidants ; Biological and medical sciences ; Bradykinin - pharmacology ; Carbamates ; Coronary vessels ; Coronary Vessels - drug effects ; Coronary Vessels - metabolism ; Coronary Vessels - physiopathology ; Down-Regulation - drug effects ; Fundamental and applied biological sciences. Psychology ; HIV ; HIV Protease Inhibitors - adverse effects ; HIV Protease Inhibitors - pharmacology ; Human immunodeficiency virus ; Human viral diseases ; Indinavir - pharmacology ; Infectious diseases ; Medical sciences ; Methionine - analogs &amp; derivatives ; Methionine - drug effects ; Microbiology ; Miscellaneous ; Muscle Contraction - drug effects ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - physiopathology ; Myography ; Nelfinavir - pharmacology ; Nitric oxide ; Nitric Oxide Synthase - genetics ; Nitric Oxide Synthase - metabolism ; Organ Culture Techniques ; Protease inhibitors ; Ritonavir - pharmacology ; RNA, Messenger - analysis ; Saquinavir - pharmacology ; Selenium Compounds - pharmacology ; Side effects ; Sulfonamides - pharmacology ; Superoxides - metabolism ; Swine ; Vasomotor System - drug effects ; Vasomotor System - physiopathology ; Viral diseases ; Virology</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2005-09, Vol.40 (1), p.12-19</ispartof><rights>2005 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Lippincott Williams &amp; Wilkins Sep 1, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</citedby><cites>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-200509010-00002$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00126334-200509010-00002$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>315,781,785,4610,27926,27927,64668,65463</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17137056$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16123675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chai, Hong</creatorcontrib><creatorcontrib>Yang, Hui</creatorcontrib><creatorcontrib>Yan, Shaoyu</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Lin, Peter H</creatorcontrib><creatorcontrib>Lumsden, Alan B</creatorcontrib><creatorcontrib>Yao, Qizhi</creatorcontrib><creatorcontrib>Chen, Changyi</creatorcontrib><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Biological and medical sciences</subject><subject>Bradykinin - pharmacology</subject><subject>Carbamates</subject><subject>Coronary vessels</subject><subject>Coronary Vessels - drug effects</subject><subject>Coronary Vessels - metabolism</subject><subject>Coronary Vessels - physiopathology</subject><subject>Down-Regulation - drug effects</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV</subject><subject>HIV Protease Inhibitors - adverse effects</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Indinavir - pharmacology</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Methionine - analogs &amp; derivatives</subject><subject>Methionine - drug effects</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - physiopathology</subject><subject>Myography</subject><subject>Nelfinavir - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase - genetics</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Organ Culture Techniques</subject><subject>Protease inhibitors</subject><subject>Ritonavir - pharmacology</subject><subject>RNA, Messenger - analysis</subject><subject>Saquinavir - pharmacology</subject><subject>Selenium Compounds - pharmacology</subject><subject>Side effects</subject><subject>Sulfonamides - pharmacology</subject><subject>Superoxides - metabolism</subject><subject>Swine</subject><subject>Vasomotor System - drug effects</subject><subject>Vasomotor System - physiopathology</subject><subject>Viral diseases</subject><subject>Virology</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkduO0zAQhiMEYg_wCshaCe5SfHbCXVXtodJKIAF7aznJWPWS2l07UeHtmdJKlfCNPeNvZn77r6obRheMtuYzZYsXFxYUFzNc6GZBleBmYbpX1SVrpaxN08jXeFZc1ZIJdVFdlfKMuJayfVtdMM2wzqjLan_rPfRTIckTRR7WT-RbThO4AmQdN6ELU8p4GcmTK2mbMCJ3c-yngCkXB_J93kFOv8MAZBkPSSwf5uN9wCjlPkQgq5RTdPkPWeYJcoDyrnrj3Vjg_Wm_rn7e3f5YPdSPX-_Xq-Vj3SvKeS0a0O1AufLOQe_bofMSnAbFqGQIMOV9Z1SrvFCNASGM8o3WjaRsYI3uxHX16dh3l9PLDGWy21B6GEcXIc3FcmxklFYI3vwHPqc5R9RmuRCaN1oIhL4coT6nUjJ4u8thi--yjNqDN5Yyi97Yszf2nzfWHKR8OE2Yuy0M59KTGQh8PAGu9G702cU-lDNnmDBUaeTkkdunEX-z_BrnPWS7ATdOGxzNOGqVNadU0ZYyWh_UcPEXbL6ntg</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Chai, Hong</creator><creator>Yang, Hui</creator><creator>Yan, Shaoyu</creator><creator>Li, Min</creator><creator>Lin, Peter H</creator><creator>Lumsden, Alan B</creator><creator>Yao, Qizhi</creator><creator>Chen, Changyi</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20050901</creationdate><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><author>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Biological and medical sciences</topic><topic>Bradykinin - pharmacology</topic><topic>Carbamates</topic><topic>Coronary vessels</topic><topic>Coronary Vessels - drug effects</topic><topic>Coronary Vessels - metabolism</topic><topic>Coronary Vessels - physiopathology</topic><topic>Down-Regulation - drug effects</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV</topic><topic>HIV Protease Inhibitors - adverse effects</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Indinavir - pharmacology</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Methionine - analogs &amp; derivatives</topic><topic>Methionine - drug effects</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - physiopathology</topic><topic>Myography</topic><topic>Nelfinavir - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase - genetics</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Organ Culture Techniques</topic><topic>Protease inhibitors</topic><topic>Ritonavir - pharmacology</topic><topic>RNA, Messenger - analysis</topic><topic>Saquinavir - pharmacology</topic><topic>Selenium Compounds - pharmacology</topic><topic>Side effects</topic><topic>Sulfonamides - pharmacology</topic><topic>Superoxides - metabolism</topic><topic>Swine</topic><topic>Vasomotor System - drug effects</topic><topic>Vasomotor System - physiopathology</topic><topic>Viral diseases</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chai, Hong</creatorcontrib><creatorcontrib>Yang, Hui</creatorcontrib><creatorcontrib>Yan, Shaoyu</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Lin, Peter H</creatorcontrib><creatorcontrib>Lumsden, Alan B</creatorcontrib><creatorcontrib>Yao, Qizhi</creatorcontrib><creatorcontrib>Chen, Changyi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chai, Hong</au><au>Yang, Hui</au><au>Yan, Shaoyu</au><au>Li, Min</au><au>Lin, Peter H</au><au>Lumsden, Alan B</au><au>Yao, Qizhi</au><au>Chen, Changyi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>40</volume><issue>1</issue><spage>12</spage><epage>19</epage><pages>12-19</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>16123675</pmid><doi>10.1097/01.qai.0000172368.05327.7b</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2005-09, Vol.40 (1), p.12-19
issn 1525-4135
1944-7884
language eng
recordid cdi_proquest_miscellaneous_21047565
source Freely Accessible Journals; MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete
subjects Animals
Antioxidants
Biological and medical sciences
Bradykinin - pharmacology
Carbamates
Coronary vessels
Coronary Vessels - drug effects
Coronary Vessels - metabolism
Coronary Vessels - physiopathology
Down-Regulation - drug effects
Fundamental and applied biological sciences. Psychology
HIV
HIV Protease Inhibitors - adverse effects
HIV Protease Inhibitors - pharmacology
Human immunodeficiency virus
Human viral diseases
Indinavir - pharmacology
Infectious diseases
Medical sciences
Methionine - analogs & derivatives
Methionine - drug effects
Microbiology
Miscellaneous
Muscle Contraction - drug effects
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - physiopathology
Myography
Nelfinavir - pharmacology
Nitric oxide
Nitric Oxide Synthase - genetics
Nitric Oxide Synthase - metabolism
Organ Culture Techniques
Protease inhibitors
Ritonavir - pharmacology
RNA, Messenger - analysis
Saquinavir - pharmacology
Selenium Compounds - pharmacology
Side effects
Sulfonamides - pharmacology
Superoxides - metabolism
Swine
Vasomotor System - drug effects
Vasomotor System - physiopathology
Viral diseases
Virology
title Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%205%20HIV%20Protease%20Inhibitors%20on%20Vasomotor%20Function%20and%20Superoxide%20Anion%20Production%20in%20Porcine%20Coronary%20Arteries&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Chai,%20Hong&rft.date=2005-09-01&rft.volume=40&rft.issue=1&rft.spage=12&rft.epage=19&rft.pages=12-19&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/10.1097/01.qai.0000172368.05327.7b&rft_dat=%3Cproquest_cross%3E901464671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233628633&rft_id=info:pmid/16123675&rfr_iscdi=true